Expert makes case for patient-specific dosimetry

06/13/2013 | MolecularImaging.net

To improve patient diagnosis and therapy, there is a need to advance patient-specific dosimetry, said Hal Anger Lectureship & Award lecturer Michael G. Stabin, a researcher at Vanderbilt University School of Medicine, in a message at the SNMMI Annual Meeting. "We have a new generation of dose phantoms and selection of sophisticated [dose planning tools and] methods ... and it's time to incorporate dose calculations into clinical therapy planning ... Our understanding of radiobiology is undergoing profound change. We will be rewriting history soon," Stabin said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ